×
About 30,210 results

ALLMedicine™ Atopic Dermatitis Center

Research & Reviews  13,369 results

Long-term efficacy and safety of intravenous injection of clonal mesenchymal stem cells...
https://doi.org/10.1111/1346-8138.15928
The Journal of Dermatology; Shin HT, Lee SH et. al.

May 15th, 2021 - Atopic dermatitis is a chronic and relapsing inflammatory skin disease that is treated with immunosuppressants. However, long-term use of immunosuppressants may cause toxicity and severe side-effects. To confirm the long-term efficacy and safety o...

Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic...
https://doi.org/10.1111/jdv.17351
Journal of the European Academy of Dermatology and Venere... Silverberg JI, Thyssen JP et. al.

May 15th, 2021 - Given the lack of head-to-head studies of systemic therapies in moderate-to-severe atopic dermatitis (AD), network meta-analyses (NMAs) can provide comparative efficacy and safety data to inform clinical decision making. In this NMA, eligible rand...

STAT6: A review of a signaling pathway implicated in various diseases with a special em...
https://doi.org/10.1016/j.prp.2021.153477
Pathology, Research and Practice; Karpathiou G, Papoudou-Bai A et. al.

May 15th, 2021 - Signal Transducer and Activator of Transcription 6 (STAT6), belonging to a family of seven similar members is primarily stimulated by interleukin(IL)-4 and IL-13, and acts as a T helper type 2 (Th2)-inducing factor. Thus, it is implicated in the p...

Childhood atopic dermatitis is associated with a decreased chance of completing educati...
https://doi.org/10.1111/jdv.17346
Journal of the European Academy of Dermatology and Venere... Pálsson K, Slagor RM et. al.

May 14th, 2021 - Atopic dermatitis (AD) has far-reaching consequences in childhood and later in working life, but information on how it affects completion of education is sparse. To compare the educational achievement of individuals with AD in childhood/adolescenc...

Mapping risk factors for Cumulative Life Course Impairment (CLCI) in patients with chro...
https://doi.org/10.1111/jdv.17348
Journal of the European Academy of Dermatology and Venere... von Stülpnagel CC, Augustin M et. al.

May 14th, 2021 - Patients with chronic skin diseases suffer from physical and psychosocial impairments which can lead to a cumulative lifelong burden. Therefore, the concept of cumulative life course impairment (CLCI) was introduced, referring to the nonreversible...

see more →

Guidelines  35 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Atopic dermatitis/Eczema | DermNet NZ
https://www.dermnetnz.org/topics/atopic-dermatitis/

Jun 24th, 2019 - Atopic dermatitis is a chronic, itchy skin condition that is very common in children but may occur at any age. It is also known as eczema and atopic eczema and was formerly known as Besnier prurigo. It is the most common form of dermatitis. Atopi...

European task force on atopic dermatitis position paper: treatment of parental atopic d...
https://doi.org/10.1111/jdv.15709
Journal of the European Academy of Dermatology and Venere... Vestergaard C, Wollenberg A et. al.

Jun 24th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...

Eczema - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK538209/
Nemeth,V.,et al

Jun 3rd, 2019 - Eczema, also known as atopic dermatitis, is the most common form of dermatitis. Genetic as well as environmental factors are thought to play a part in the pathogenesis. Eczema is most commonly seen in children but can be seen in adults. People ...

The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing...
https://doi.org/10.1542/peds.2019-0281

Mar 17th, 2019 - This clinical report updates and replaces a 2008 clinical report from the American Academy of Pediatrics, which addressed the roles of maternal and early infant diet on the prevention of atopic disease, including atopic dermatitis, asthma, and foo...

see more →

Drugs  639 results see all →

Clinicaltrials.gov  14,615 results

Long-term efficacy and safety of intravenous injection of clonal mesenchymal stem cells...
https://doi.org/10.1111/1346-8138.15928
The Journal of Dermatology; Shin HT, Lee SH et. al.

May 15th, 2021 - Atopic dermatitis is a chronic and relapsing inflammatory skin disease that is treated with immunosuppressants. However, long-term use of immunosuppressants may cause toxicity and severe side-effects. To confirm the long-term efficacy and safety o...

Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic...
https://doi.org/10.1111/jdv.17351
Journal of the European Academy of Dermatology and Venere... Silverberg JI, Thyssen JP et. al.

May 15th, 2021 - Given the lack of head-to-head studies of systemic therapies in moderate-to-severe atopic dermatitis (AD), network meta-analyses (NMAs) can provide comparative efficacy and safety data to inform clinical decision making. In this NMA, eligible rand...

STAT6: A review of a signaling pathway implicated in various diseases with a special em...
https://doi.org/10.1016/j.prp.2021.153477
Pathology, Research and Practice; Karpathiou G, Papoudou-Bai A et. al.

May 15th, 2021 - Signal Transducer and Activator of Transcription 6 (STAT6), belonging to a family of seven similar members is primarily stimulated by interleukin(IL)-4 and IL-13, and acts as a T helper type 2 (Th2)-inducing factor. Thus, it is implicated in the p...

Childhood atopic dermatitis is associated with a decreased chance of completing educati...
https://doi.org/10.1111/jdv.17346
Journal of the European Academy of Dermatology and Venere... Pálsson K, Slagor RM et. al.

May 14th, 2021 - Atopic dermatitis (AD) has far-reaching consequences in childhood and later in working life, but information on how it affects completion of education is sparse. To compare the educational achievement of individuals with AD in childhood/adolescenc...

Mapping risk factors for Cumulative Life Course Impairment (CLCI) in patients with chro...
https://doi.org/10.1111/jdv.17348
Journal of the European Academy of Dermatology and Venere... von Stülpnagel CC, Augustin M et. al.

May 14th, 2021 - Patients with chronic skin diseases suffer from physical and psychosocial impairments which can lead to a cumulative lifelong burden. Therefore, the concept of cumulative life course impairment (CLCI) was introduced, referring to the nonreversible...

see more →

News  1,527 results

Latest Emollient Data Discouraging for Atopic Dermatitis Prevention
https://www.medscape.com/viewarticle/950331

May 2nd, 2021 - Emollients don't prevent atopic dermatitis (AD), but they might have untapped potential as treatment, two new studies suggest. The results of a prevention study, in which parents slathered their babies with petrolatum, are particularly discouragin...

Atopic Dermatitis Genes Vary With Ethnicity
https://www.medscape.com/viewarticle/950193

Apr 28th, 2021 - Genetic biomarkers for atopic dermatitis (AD) vary from one ethnic group to another, with a mutation in the interleukin-17 receptor A (IL-17RA) gene particularly important in Korean patients, researchers say. The finding moves researchers another ...

Multidisciplinary Approach Touted for Atopic Dermatitis
https://www.medscape.com/viewarticle/949917

Apr 24th, 2021 - Bringing pharmacists, allergists, and dermatologists together to discuss patient care can improve outcomes for children with atopic dermatitis, researchers say. "I think we really gained insight to how a more holistic approach benefited the patien...

Novel S1P-Receptor Modulator Shows Promise in Phase 2b AD Trial
https://www.medscape.com/viewarticle/949915

Apr 23rd, 2021 - A novel, highly selective oral sphingosine 1-phosphate (S1P)–receptor modulator showed promise as a treatment for atopic dermatitis (AD) in a 12-week phase 2b trial, according to researchers who released their findings at the American Academy of D...

Tralokinumab Gets Nod for Atopic Dermatitis in Europe
https://www.medscape.com/viewarticle/949912

Apr 22nd, 2021 - On Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion for the IL-13 inhibitor tralokinumab (Adtralza) for the treatment of adults with moderate-to-severe atopic dermat...

see more →

Patient Education  25 results see all →